New England Biolabs Expands its Luna® Portfolio with One-Step Master Mix for Multiplex RT-qPCR

The new Luna Probe One-Step RT-qPCR 4X Mix with UDG enables minimal sample handling, efficient performance and sensitive detection of up to five target RNA sequences, including those of low abundance for pathogen detection. IPSWICH, MA (October 1, 2020): New England Biolabs® (NEB®) today announced the launch of its Luna Probe One-Step RT-qPCR 4X Mix with... Read more

Phenomenex Announces Direct Sales and Support within the Czech Republic and Slovakia

Torrance, Calif. (10.1.2020) – Phenomenex, Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, has announced that it will begin to directly serve customers in the Czech Republic and Slovakia, effective October, 01 2020. The new office will be operated out of Prague.  Phenomenex is a leading player... Read more

PCR Biosystems introduces kit for reliable quantification of libraries prepared for Illumina® NGS systems

Caption: PCR Biosystems NGSBIO Library Quant Kit for Illumina®.To download this image, please click here. London, UK (30 September 2020) – PCR Biosystems, the UK-based PCR experts, have expanded their range of specialist molecular biology kits with the introduction of NGSBIO Library Quant Kit for Illumina®. The new kit contains all the components necessary for accurate and sensitive quantification of DNA libraries... Read more

Bio-Techne Announces Grand Opening of GMP Manufacturing Facility

MINNEAPOLIS, Sept. 30, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced the grand opening of its approximately 61,000 square foot state-of-the-art GMP (Good Manufacturing Practices) manufacturing facility. Located in St. Paul, MN, the new facility is dedicated to supporting large-scale production of GMP-grade materials, including E. coli-derived recombinant proteins, which are an essential component for... Read more

Zymo Research Granted CE IVD Mark for Sample Collection Devices

SAFE AND RELIABLE SAMPLE PRESERVATION AT AMBIENT TEMPERATURE FOR IVD APPLICATIONS Zymo Research was granted the CE IVD mark for its DNA/RNA Shield™ reagent and collection devices. IRVINE, Calif., (Sept. 25, 2020) — Zymo Research announced that three of its DNA/RNA Shield™ collection devices: 1) DNA/RNA Shield™ collection tube w/ swab, 2) DNA/RNA Shield™ Saliva/Sputum Collection Kit, and 3) DNA/RNA Shield™ Fecal Collection... Read more

Clear Labs Granted EUA by FDA for SARS-CoV-2 Novel Descriptive Diagnostic

NGS-enabled platform tracks infection clusters for contact tracing and monitors emerging mutations, combining once separate aspects of screening and genomic surveillance SAN CARLOS, CALIF. (PRWEB) SEPTEMBER 24, 2020 Clear Labs, providers of the only fully automated and intelligent next-generation sequencing (NGS) in vitro diagnostic (IVD) platform, today announced that the U.S. Food and Drug Administration (FDA) has... Read more

BioTtechne Announces Commercial Release of New Co-detection Assays for Simultaneous Detection of RNA and Protein on the Same Sample

Expanding Bio-Techne’s lead in providing multi-omics research tools to co-detect RNA and protein targets MINNEAPOLIS, Sept. 22, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD)-branded RNAscope™ technology with release of the new RNA-Protein Co-Detection Assays. The RNAscope technology is an advanced in situ hybridization (ISH) assay that enables... Read more

Bio-Techne Rebrands B-MoGen Biotechnologies as Part of the R&D Systems Product Portfolio

MINNEAPOLIS, Sept. 21, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that the B-MoGen Biotechnologies portfolio of genome engineering services, GMP therapeutic manufacturing services, and its proprietary transposon-transposase gene transfer system, TcBuster™, will be rebranded as R&D Systems. As part of the rebranding, the B-MoGen Biotechnologies website will be retired. Service details and purchasing... Read more

Bio-Techne and QIAGEN Announce Expansion and Extension of Exosome Partnership

MINNEAPOLIS, Sept. 17, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) and QIAGEN N.V. today announced the expansion and extension of a non-exclusive partnership to co-market exosome technology to existing and potential biopharma partners as well as the joint development of new exosome based products.   The agreement grants QIAGEN a non-exclusive development license to Bio-Techne’s exosome... Read more

Fluidigm Joins Global Consortium of Cancer Prevention Experts

CANCERPREV Cross-Disciplinary Program Expands Knowledge of Cancer Development to Deliver New Insights into Prevention Strategies Principal Focus on Advancing Understanding of Breast and Skin Cancer Risks SOUTH SAN FRANCISCO, Calif., Sept. 16, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced its participation in CANCERPREV, a... Read more